Biostax Corp Biostax Corp Biostax Corp
  • Home
  • About
    • Overview
    • Management
    • Board of Directors
  • Programs
    • Overview
    • HIV Treatment EX-US
    • NASH/AIH/CLD: JKB-122
    • BiostaxRx: Inflammaging
  • Investors
    • Overview
    • News
    • Events
    • SEC Filings
    • Financial
    • Stock
    • Governance
    • FAQ
  • Contact
    • Email Sign Up
  • Home
  • About
    • Overview
    • Management
    • Board of Directors
  • Programs
    • Overview
    • HIV Treatment EX-US
    • NASH/AIH/CLD: JKB-122
    • BiostaxRx: Inflammaging
  • Investors
    • Overview
    • News
    • Events
    • SEC Filings
    • Financial
    • Stock
    • Governance
    • FAQ
  • Contact
    • Email Sign Up

Section 1

Innovative Biotech Portfolio Hub and Spoke Multinational

Investment, Discovery, Development and Commercialization Engine

Contact Us for Partnering Opportunities

Contact Now

Section 2

Our Most Recent Stack

A small molecule immune modulator ready for a BIG future

Learn about JKB-122

Discover the Next Generation

This website may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions, and expectations of Biostax’s future economic performance, considering the information currently available to it. These statements are not statements of historical fact. Although Biostax believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Biostax does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Biostax will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks, and uncertainties, some of which are not currently known to us, that may cause Biostax’s actual results, performance, or financial condition to be materially different from the expectations of future results, performance, or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory review and approval of our prospective products, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

The information provided in this website is intended for general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. This information is not intended to diagnose, treat, cure or prevent any disease.

© Biostax Corp. 2023